Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo.
American Heart Journal.
Times cited: 61
Abciximab and bleeding during coronary surgery: Results from the EPILOG and EPISTENT trials.
Annals of Thoracic Surgery.
Times cited: 63
Outcomes at 1 year and economic implications of platelet glycoprotein IIb/IIIa blockade in patients undergoing coronary stenting: Results from a multicentre randomised trial.
Times cited: 327